Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Valuck

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Pharmacoepidemiology and Drug Safety|April 14, 2020
Validity of administrative claims-based algorithms for ventricular arrhythmia and cardiac arrest in the pediatric populationAngela S Czaja, Kathryn Collins, Robert J Valuck, et al.
Arthritis and Rheumatism|January 31, 2009
Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis modelCheryll Williams-Skipp, Thiagarajan Raman, Robert J Valuck, et al.
The Journal of Pediatrics|July 10, 2020
Increased Odds of Ventricular Arrhythmias Associated with Selective Serotonin Reuptake Inhibitor Use among the Pediatric and Young Adult Population: A Case-Control StudyAngela S Czaja, Heather D Anderson, Debashis Ghosh, et al.
The Journal of Clinical Psychiatry|November 13, 2018
Access to Psychotropic Medication via Prescription Is Associated With Choice of Psychotropic Medication as Suicide Method: A Retrospective Study of 27,876 Suicide AttemptsTalia L Brown, Peter M Gutierrez, Gary K Grunwald, et al.
Annals of Internal Medicine|July 30, 2009
An electronic practice-based network for observational comparative effectiveness researchWilson D Pace, Maribel Cifuentes, Robert J Valuck, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic diseaseKavita V Nair, Pamela Wolfe, Robert J Valuck, et al.
Journal of Managed Care & Specialty Pharmacy|April 30, 2020
Effects of a 3-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals With Chronic DiseaseKavita V Nair, Pamela Wolfe, Robert J Valuck, et al.
The American Journal of Psychiatry|June 2, 2007
Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIsAnne M Libby, David A Brent, Elaine H Morrato, et al.
Neurology|February 19, 2016
Multiple sclerosis prevalence in the United States commercially insured populationPiyameth Dilokthornsakul, Robert J Valuck, Kavita V Nair, et al.
The American Journal of Psychiatry|August 3, 2007
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIsRobert J Valuck, Anne M Libby, Heather D Orton, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Pharmacoepidemiology and Drug Safety|April 14, 2020
Validity of administrative claims-based algorithms for ventricular arrhythmia and cardiac arrest in the pediatric populationAngela S Czaja, Kathryn Collins, Robert J Valuck, et al.
Arthritis and Rheumatism|January 31, 2009
Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis modelCheryll Williams-Skipp, Thiagarajan Raman, Robert J Valuck, et al.
The Journal of Pediatrics|July 10, 2020
Increased Odds of Ventricular Arrhythmias Associated with Selective Serotonin Reuptake Inhibitor Use among the Pediatric and Young Adult Population: A Case-Control StudyAngela S Czaja, Heather D Anderson, Debashis Ghosh, et al.
The Journal of Clinical Psychiatry|November 13, 2018
Access to Psychotropic Medication via Prescription Is Associated With Choice of Psychotropic Medication as Suicide Method: A Retrospective Study of 27,876 Suicide AttemptsTalia L Brown, Peter M Gutierrez, Gary K Grunwald, et al.
Annals of Internal Medicine|July 30, 2009
An electronic practice-based network for observational comparative effectiveness researchWilson D Pace, Maribel Cifuentes, Robert J Valuck, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic diseaseKavita V Nair, Pamela Wolfe, Robert J Valuck, et al.
Journal of Managed Care & Specialty Pharmacy|April 30, 2020
Effects of a 3-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals With Chronic DiseaseKavita V Nair, Pamela Wolfe, Robert J Valuck, et al.
The American Journal of Psychiatry|June 2, 2007
Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIsAnne M Libby, David A Brent, Elaine H Morrato, et al.
Neurology|February 19, 2016
Multiple sclerosis prevalence in the United States commercially insured populationPiyameth Dilokthornsakul, Robert J Valuck, Kavita V Nair, et al.
The American Journal of Psychiatry|August 3, 2007
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIsRobert J Valuck, Anne M Libby, Heather D Orton, et al.
Pageof 7